Diversity language in US medical research agency grants declined 25% since 2024

Analysis agrees with news report findings that suggest greater scrutiny of research pertaining to diversity, equity, and other topics of political interest

2025-12-12

(Press-News.org) Words reflecting diversity language have appeared less frequently in grants awarded by the National Institutes of Health (NIH) since the 2024 US presidential election, with a 25% relative decrease between January 2024 and June 2025, finds a study in the Christmas issue of The BMJ.

News reports have indicated that US federal agencies have recently limited or discouraged use of words related to diversity, health inequities, and other scientific subjects commanding political attention in NIH research grants.

News reports also suggest that researchers may be modifying their language or research topics to align with federal priorities, but this issue has not been rigorously evaluated.

To explore this further, researchers measured changes in diversity language in newly awarded NIH grant abstracts during 2024 and 2025, using a list of words based on existing news reports from the New York Times and PEN America, ranging from abortion, climate change, and disability to gender, racism, and women.

Overall, 17,701 grants were analysed. The rate of words reflecting diversity language decreased sharply between October and November 2024, from 11.11 to 5.42 words per 1,000, a 51% relative decrease. The decrease persisted through 2025, with an overall relative decrease of 25% between January 2024 and June 2025.

In an additional analysis of 1,967 pairs of the same grants in 2024 and 2025, words reflecting diversity language were deleted from grant abstracts at a 10-fold higher rate than other (control) words in 2025.

“This result is consistent with anecdotal evidence that researchers have modified language to prevent grant abstracts from being flagged for governmental review, suggesting a limitation on researchers’ ability to freely use specific terms in federal research grants,” say the researchers.

These are observational findings, so no firm conclusions can be drawn about cause and effect, and the authors acknowledge that their analysis was limited to eight months, they used lists of words compiled by news outlets, and did not separate words reflecting diversity language into separate domains, which may obscure changes in the relative prevalence of certain subjects over others.

Nevertheless, they say: “Our analysis directionally agrees with findings of news reports, which broadly suggest greater scrutiny of research pertaining to diversity, equity, and other topics of political interest.”

They add: “Future work should consider monitoring changes over a longer period and should consider using a semantic or word embedding strategy to capture different subtopics.”

END

ELSE PRESS RELEASES FROM THIS DATE:

Concern over growing use of AI chatbots to stave off loneliness

2025-12-12

AI chatbot systems, such as ChatGPT, Claude, and Copilot, are used increasingly as confidants of choice, but turning to AI chatbots for companionship and emotional support is a cause for concern, especially in younger people, say experts in the Christmas issue of The BMJ. They warn that “we might be witnessing a generation learning to form emotional bonds with entities that lack capacities for human-like empathy, care, and relational attunement” and say evidence based strategies for reducing ...

Biomedical authors often call a reference “recent” — even when it is decades old, analysis shows

2025-12-12

Authors in biomedical journals frequently describe cited evidence as “recent,” yet the actual age of the references behind these phrases has rarely been measured. To measure how recent the "recent" studies really are, researchers based in Spain analysed 1000 biomedical articles containing 20 predefined “recent” expressions directly linked to a citation. Their findings in the Christmas issue of The BMJ show that the citation lag ranged from 0 to 37 years, with a median of 4 years and a mean of 5.5 years. The most frequent ...

The Lancet: New single dose oral treatment for gonorrhoea effectively combats drug-resistant infections, trial finds

2025-12-12

A single-dose oral medication called zoliflodacin shows promise as a new treatment for antibiotic-resistant gonorrhoea, according to a phase 3 clinical trial published in The Lancet. The study found that one dose of zoliflodacin was as effective as the current standard treatment, which combines two antibiotics: an injection of ceftriaxone followed by an oral dose of azithromycin. Gonorrhoea is one of the most common sexually transmitted infections, affecting over 82 million people globally each year. However, it is increasingly difficult to treat as the bacteria that cause ...

Proton therapy shows survival benefit in Phase III trial for patients with head and neck cancers

2025-12-12

At five years, 90.9% of proton patients were alive compared to 81% with traditional radiation Proton therapy also showed benefits in quality of life, such as less feeding tube dependence, less difficulty swallowing, less dry mouth, and higher immune cell counts Study represents the largest randomized Phase III trial comparing proton to traditional radiation with photons for oropharyngeal cancer patients HOUSTON, DECEMBER 11, 2025 ― A new study published today in The Lancet showed a significant ...

Blood test reveals prognosis after cardiac arrest

2025-12-12

A blood biomarker yet to be used in cardiac arrest care can give a clearer picture of the extent of brain damage after a cardiac arrest. This has been shown in a large international multicentre study led by researchers at Lund University that has been published in The Lancet Respiratory Medicine. Worldwide, around four million people each year suffer a sudden cardiac arrest “This will transform care for these patients,” says researcher Marion Moseby Knappe. Key facts about the study: clinical prospective multicentre study // 819 patients // out-of- hospital cardiac arrest // A simple blood test that can very accurately predict the chance of survival with good recovery ...

UBCO study finds microdosing can temporarily improve mood, creativity

2025-12-12

A new UBC Okanagan study found that people who microdose psychedelics feel better on the days they take them—but those boosts don’t seem to last. This suggests, says Dr. Michelle St. Pierre, that perceived benefits may be acute rather than long lasting. Dr. St. Pierre is a post-doctoral psychology researcher with UBCO’s Irving K. Barber Faculty of Arts and Sciences. She recently published a study in Psychopharmacology that tracks the daily experiences of people who microdose with psychedelics. Microdosing involves ingesting small amounts of a psychedelic substance, commonly psilocybin mushrooms or lysergic acid diethylamide (LSD). “Most ...

An ECOG-ACRIN imaging study solves a long-standing gap in metastatic breast cancer research and care: accurately measuring treatment response in patients with bone metastases

2025-12-11

A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an improved method for predicting treatment benefits in patients with hormone receptor-positive (HR+) metastatic breast cancer that has spread primarily or exclusively to the bones. These patients make up a large portion of individuals who are living with advanced breast cancer—yet are routinely excluded from clinical trials that rely on standard imaging-based assessments (i.e., RECIST 1.1). The study demonstrated that metabolic change assessed by FDG-PET/CT accurately predicted progression-free ...

Cleveland Clinic presents final results of phase 1 clinical trial of preventive breast cancer vaccine study

2025-12-11

December 11, 2025, CLEVELAND: Cleveland Clinic researchers are presenting final Phase 1 data from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease. The study team found that the investigational vaccine produced an immune response in the majority (74%) of all participants and was safe and well tolerated. They determined the maximum tolerated dose and described that side effects primarily consisted of mild skin inflammation at the injection site. The findings, which will inform the ...

Nationally renowned anesthesiology physician-scientist and clinical operations leader David Mintz, MD, PhD, named Chair of the Department of Anesthesiology at the UM School of Medicine

2025-12-11

University of Maryland School of Medicine Dean Mark T. Gladwin, MD, along with University of Maryland Medical Center (UMMC) President Bert O’Malley, MD, today announced the appointment of C. David Mintz, MD, PhD, to be the next Chair of the Department of Anesthesiology, and Chief of the Anesthesiology Clinical Service (“Chief of Anesthesiology”) at UMMC. Dr. Mintz, a neuroanesthesiologist and nationally recognized leader in research, education, and perioperative operations, will be installed as the Martin Helrich Endowed Professor and Chair of Anesthesiology. He will begin his new position in July, 2026. Dr. Mintz brings an ...

Clean water access improves child health in Mozambique, study shows

2025-12-11

In Mozambique, more than one in three children under five suffer from stunting, or impaired physical growth, a sign of chronic undernutrition. New research from the University of Notre Dame shows that improving access to safe drinking water can reduce the odds of stunting by about 20 percent, making it the most effective Water, Sanitation and Hygiene (WASH) intervention for child growth. The study, published in the journal Children, is one of the few studies to use nationally representative data from Mozambique to examine the independent and combined effects of access to water and sanitation on child growth outcomes (stunting ...

LAST 30 PRESS RELEASES:

New UBCO research challenges traditional teen suicide prevention models